$122.00
Contents: 40mg of MOTS-C
Form: Lyophilized Powder
Purity: ≥ 99% USA Tested, Verified Purity (HPLC Tested)
Verification: Verifiable COA’s (Batch-Matched)
Emerging Research Evidence:
MOTS-c 40mg is studied in pre-clinical laboratory models as a high-capacity ‘Energy Messenger’ used to examine broad-spectrum cellular power-plant signaling and systemic hormonal pathway stability. Research systems focus on large-scale signal timing, multi-pathway integration, and exhaustive molecular communication within controlled experimental environments, providing a blueprint for total cellular coordination without reference to therapeutic or physiological outcomes.
Keep product in cool, dark place.
Sold for Research Use Only / Not FDA Regulated
Batch-verified inventory. See 3rd Party COA.
In stock
MOTS-c 40mg is a high-capacity research standard studied for its role as a primary mitochondrial signaling messenger that bridges cellular power production and systemic hormonal coordination. In laboratory models, this 40mg format is utilized to examine broad-spectrum energy signaling and the comprehensive blueprints of endocrine pathway stability, specifically those involving complex hormonal precursor modulation.
In experimental settings, researchers utilize this concentration to track how the cell’s ‘Power Plant’ sends sustained instructions to the nucleus to regulate large-scale metabolic signaling and multi-pathway cross-talk. The 40mg tier allows for an exhaustive analysis of molecular response patterns and the long-term timing of messages required for cellular stamina. These studies focus strictly on the total flow of energy signals and receptor-mediated coordination within controlled research systems, rather than physiological performance or clinical outcomes.
CAS Number: 1627580-64-6
Molecular Formula: C₁₀₁H₁₅₂N₂₈O₂₂S₂
Molecular Weight (average): ~2174.6 g/mol
Monoisotopic Mass: ~2173.11 Da
Parent Compound / Origin:
Encoded by MT-RNR1 (mitochondrial 12S rRNA) small open reading frame (sORF).
Mitochondrial-derived peptide MOTS-C
Mitochondrial open reading frame of the 12S rRNA-c
MOTS-C is utilized in pre-clinical research models across the following areas:
Mitochondrial Signaling Pathway Research
Investigating mitochondria-to-nucleus communication, intracellular signaling coordination, and pathway integration.
Cellular Energy-Associated Signaling
Studying molecular signaling pathways related to cellular energy sensing and metabolic signal transduction in laboratory systems.
Redox & Stress-Response Signaling Models
Examining signaling behavior associated with redox balance, oxidative-stress markers, and cellular response pathways.
Intracellular Communication & Pathway Cross-Talk
Researching interactions between mitochondrial signaling molecules and nuclear-encoded signaling networks.
Signal Adaptation & Biomarker Modulation
Evaluating pathway responsiveness and biomarker activity under controlled experimental conditions.
MOTS-c 40mg is utilized as a high-capacity research map for studying the ‘Energy Messenger’ pathways connecting the cell’s power plant to its control center. In laboratory settings, this 40mg format allows researchers to track the broad-spectrum timing and flow of metabolic signals, including those involved in complex hormonal pathway stability. All research remains investigational and exploratory, focused on the comprehensive communication between mitochondria and the nucleus rather than therapeutic or physiological application.
MOTS-C is intended for laboratory research use only. Not for human or veterinary consumption. Not approved by the FDA for therapeutic or diagnostic use. All referenced studies are pre-clinical and exploratory.
For Research Use Only — Not for Human or Veterinary Use. Not evaluated or approved by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. All information on this website is provided strictly for laboratory research and educational purposes. Nothing herein constitutes medical, clinical, or legal advice, nor an endorsement of non-laboratory use. Any discussion of specific peptides or potential research findings is informational only and must not be interpreted as guidance for use in or on humans or animals.
